Dolar, Tommy D.

HRN: 29 02 59  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/20/2026
05/26/2026
IV
4.5gm
Q8
Septicemia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: